These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 28284046)
1. Breaking the cycle: A comparison between intravenous immunoglobulins and high dosage prednisone in the treatment of medically intractable epilepsy in children. Tang-Wai R; Mailo J; Rosenblatt B Seizure; 2017 Apr; 47():34-41. PubMed ID: 28284046 [TBL] [Abstract][Full Text] [Related]
2. Intravenous Immunoglobulin as a Treatment for Intractable Epilepsy Secondary to Focal Cortical Dysplasia: A Meta-analysis. Al Amrani F; Dudley R; Bello-Espinosa LE; Rosenblatt B; Srour M; Sébire G Pediatr Neurol; 2017 Nov; 76():79-81. PubMed ID: 28969879 [TBL] [Abstract][Full Text] [Related]
3. Intravenous immunoglobulin therapy is rarely effective as the initial treatment in West syndrome: A retrospective study of 70 patients. Matsuura R; Hamano S; Hirata Y; Oba A; Suzuki K; Kikuchi K J Neurol Sci; 2016 Sep; 368():140-4. PubMed ID: 27538618 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of intravenous immunoglobulin in a cohort of children with drug-resistant epilepsy. Bello-Espinosa LE; Rajapakse T; Rho JM; Buchhalter J Pediatr Neurol; 2015 May; 52(5):509-16. PubMed ID: 25882078 [TBL] [Abstract][Full Text] [Related]
6. Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura. Jayabose S; Mahmoud M; Levendoglu-Tugal O; Sandoval C; Ozkaynak F; Giamelli J; Visintainer P J Pediatr Hematol Oncol; 1999; 21(6):514-7. PubMed ID: 10598663 [TBL] [Abstract][Full Text] [Related]
7. Immunoglobulin treatment in epilepsy, a review of the literature. van Engelen BG; Renier WO; Weemaes CM; Gabreels FJ; Meinardi H Epilepsy Res; 1994 Dec; 19(3):181-90. PubMed ID: 7698094 [TBL] [Abstract][Full Text] [Related]
8. The use of immunoglobulins in the treatment of human epilepsy. Villani F; Avanzini G Neurol Sci; 2002 Apr; 23 Suppl 1():S33-7. PubMed ID: 12032585 [TBL] [Abstract][Full Text] [Related]
9. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112 [TBL] [Abstract][Full Text] [Related]